In addition, this agrees with our present study, where EPHX2 overexpression significantly correlated with TNBC, a heterogeneous and aggressive form of breast cancer, lacking therapeutic targets and with poor prognosis [37]. The gene discussed is EPHX2; the disease is breast carcinoma.